UPA Enclomiphene 15mg

UPA Enclomiphene 15mg is an oral product listed as containing Enclomiphene Citrate, a non-steroidal Selective Oestrogen Receptor Modulator (SERM). Each pack contains 50 tablets, with a stated strength of 15mg per tablet.

Enclomiphene is the trans-isomer of clomiphene and has been investigated for its potential to stimulate the body's natural testosterone production by influencing reproductive hormone signalling.

Unlike testosterone replacement therapy (TRT), which introduces testosterone directly into the body, enclomiphene acts on the hypothalamic-pituitary-gonadal (HPG) axis to encourage endogenous testosterone production.

Enclomiphene has attracted research interest for its potential applications in male secondary hypogonadism, reproductive hormone regulation and fertility preservation. However, it remains an investigational medication and is not approved for routine therapeutic use in many jurisdictions.

What UPA Enclomiphene Is Used For

Enclomiphene Citrate has been investigated primarily for its potential effects on natural testosterone production and reproductive hormone regulation in men.

Its recognised pharmacological effects and research areas include:

• Natural Testosterone Production: Investigated for its ability to increase endogenous testosterone levels in men with certain forms of secondary hypogonadism.
• Hormonal Regulation: Influences the hypothalamic-pituitary-gonadal axis, which regulates testosterone production and reproductive function.
• Luteinising Hormone (LH) Stimulation: Can increase LH secretion, which stimulates testosterone production in the testes.
• Follicle-Stimulating Hormone (FSH) Activity: Can increase FSH levels, a hormone involved in sperm production and reproductive health.
• Male Fertility Research: Studied for its potential to maintain sperm production while increasing testosterone levels.
• Secondary Hypogonadism: Investigated as a potential treatment for men experiencing low testosterone due to inadequate stimulation from the pituitary gland.
• Reproductive Hormone Balance: Examined for its effects on testosterone, LH and FSH concentrations.
• Post-Cycle Hormonal Recovery: Has attracted interest in bodybuilding communities for restoring testosterone production following anabolic steroid use, although this application has not been clinically established or approved.

Important: Enclomiphene is not an anabolic steroid and does not directly stimulate muscle growth. Its primary effects are associated with reproductive hormone signalling.

How UPA Enclomiphene Works

Enclomiphene Citrate belongs to a class of compounds known as Selective Oestrogen Receptor Modulators (SERMs).

It works primarily by interfering with oestrogen-mediated negative feedback at the hypothalamus, influencing the body's natural reproductive hormone signalling pathways.

By reducing this negative feedback, enclomiphene can increase the release of gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce luteinising hormone (LH) and follicle-stimulating hormone (FSH).

Its primary mechanisms include:

• Oestrogen Receptor Modulation: Interacts with oestrogen receptors involved in reproductive hormone regulation.
• Hypothalamic Activity: Reduces oestrogen-mediated negative feedback, influencing the release of reproductive hormones.
• GnRH Signalling: Encourages increased gonadotropin-releasing hormone activity within the hypothalamic-pituitary system.
• LH Production: Stimulates luteinising hormone secretion, supporting natural testosterone production in men.
• FSH Production: Increases follicle-stimulating hormone activity, which plays an important role in sperm development.
• Endogenous Testosterone Stimulation: May increase testosterone production in men with a responsive hypothalamic-pituitary-testicular axis.
• Sperm Production: Has demonstrated the ability to maintain sperm concentrations in certain clinical studies, unlike exogenous testosterone therapy, which can suppress sperm production.
• Hormonal Feedback Regulation: Influences the body's natural hormonal feedback mechanisms without directly supplying testosterone.

Unlike aromatase inhibitors, enclomiphene does not primarily reduce oestrogen production. Instead, it modifies oestrogen receptor signalling to influence the release of reproductive hormones.

Possible Side Effects

Enclomiphene Citrate may cause adverse effects associated with changes in reproductive hormone activity and oestrogen receptor signalling. Human clinical research remains limited, particularly regarding long-term safety.

Common or Recognised Side Effects:

Reported adverse effects and potential safety concerns include:

• Headaches.
• Hot flushes or increased sweating.
• Nausea or gastrointestinal discomfort.
• Dizziness or light-headedness.
• Mood changes or irritability.
• Anxiety or emotional sensitivity.
• Difficulty sleeping.
• Changes in libido.
• Acne or oily skin.
• Increased circulating testosterone levels.
• Increased oestradiol levels in some men.